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ABSTRACT 
Synthesis of Chemical Models of Hydrolase Enzymes for Intramolecular Catalysis 
                                                        by 
                                            Cornelius N. Ndi 
Most nuclease enzymes can hydrolyze phosphoester bonds (in DNA and RNA) by 
using metal ions cofactors that coordinate and activate water molecules in the 
enzymes’ active sites.   However, there are some hydrolase enzymes (including 
nucleases) that can function without the aid of metal ions.  2,6-Di(1H-imidazol-2-
yl)phenol, a model compound for hydrolase enzyme, was synthesized by the 
reaction between ethylenediamine and dimethyl-3-carboxysalicylate, initially 
resulting in the formation of diimidazoline.  The diimidazoline was subsequently 
aromatized to the diimidazole by dehydrogenation over palladium.  The overall 
reaction yield was low; therefore, other dehydrogenation transformation reactions 
were tried but all failed to improve the yield.  Converting this diimidazolphenol 
into diimidazolphenyl monophoshpate derivative was attempted but failed to give 
desired products.   
Synthesis of 2,2'-anthracene-1,8-diylbis-1H-imidazole, another model compound 
for hydrolase enzymes, was attempted using dimethyl –1,8 –
anthracenedicarboxylate, but synthesis was unsuccessful due to solubility problem.   
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CHAPTER 1 
INTRODUCTION 
Phosphate esters are common in nature.  They exist in living organisms as 
DNA and RNA and are encountered in the environment as insecticides and 
pesticides.  These esters are known to be very stable; DNA and RNA have half-
lives of several hundreds of years.  The key for successful hydrolysis of 
phosphodiester bonds is the delivery of a primary nucleophile at the reaction center 
(phosphorus atom).
1
  Although most hydrolytic enzymes use metal ion cofactors, a 
few enzymes are known to do so without metal ions.  Such enzymes and their 
model compounds have attracted increasing interest in the recent years due to their 
potential applications in pharmaceutical industry. 
Intramolecular Catalysis 
The acceleration of chemical transformation at one site of a molecular 
species through the involvement of a neighboring functional (catalytic) group in 
the same molecule has been reported in literature, using enzymes as well as model 
compounds
2
.  The use of the term autocatalysis (intramolecular catalysis) is 
restricted to chemical systems where the substrate and the catalyst are in the same 
compound. 
Intramolecular catalysis, where the substrate and catalytic group are brought 
close together by specific spacers has the following advantages: 
13 
 
1. Increasing the effective concentration of substrate and catalytic 
group. 
2. Enhancing the catalytic reaction rate due to the optimal 
molecular geometry that results in favorable interaction between the 
substrate and the catalytic site.  Two to three orders of magnitude of 
rate enhancements have been observed in model compounds. 
3. Although less effective than enzymes (with rate enhancements 
of five to nine orders of magnitude), these model compounds help 
understand mechanism of action of enzymes. 
Enzymes 
Enzymes are biological catalysts and are required by most metabolic 
reactions to occur at required rates.  Each cell contains over 500 different enzymes 
to enable it to function properly.  The type of enzyme required depends on the 
nature and function of the cell in the living organism.  Over 2000 different 
enzymes are known and described in variable depths. 
As proteins, enzymes have characteristic primary, secondary, and tertiary 
structures.  Sequences of amino acids linked by peptide bonds form the primary 
structure.  Only 20 amino acids are known to constitute all types of proteins that 
vary in sizes.  The secondary and tertiary structures are involved in determining the 
three-dimensional nature of the enzyme. 
14 
 
Enzymes involved in cellular metabolic reactions often have quaternary 
structures as well.  This means that these enzymes have more than one polypeptide 
subunits that cooperate in their functions.  In some metabolic systems, more 
complex forms of enzyme organization are observed.  An example of this level of 
organization is observed in the fatty acid synthetic pathway in plants and bacteria 
where seven different enzymes physically associate with each other to catalyze a 
series of reactions.
3
 
Enzyme Catalysis 
Enzymes, E, are very sensitive to temperature, pH, and solvents.  Despite 
these disadvantages as proteins, they tend to be more efficient catalysts than 
synthetic catalysts which are less sensitive to such factors.  As catalysts, they 
follow the normal rules for catalysis:  
1) They do not catalyze thermodynamically unfavorable reactions. 
2) They remain unchanged at the end of the reaction. 
3) They do not change the direction of a reaction. 
4) They do not change the equilibrium of a reaction but increase the rate 
at which the equilibrium is reached. 
Enzymes lower the activation energy of metabolic reactions by forming an 
intermediate enzyme-metabolite complex, E – S, with one or more of the 
15 
 
metabolites (Figure 1).  This complex subsequently breaks down to give product 
and enzyme.  This process takes place in the most important catalytic region of the 
enzyme called the active site.  The active site of an enzyme is a small crevice 
composed of specific amino acids that are directly involved in catalysis.  Some of 
these are shown in Table 1.  
 
Figure 1.  Energy diagram for a catalyzed versus non-catalyzed reaction
4
 
(adapted) 
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Table 1.  Examples of amino acids that are usually involved in the active 
sites of enzymes
3
 
Amino acid Side group` Interaction with substrate 
Serine -OH Hydrogen bonding 
Cysteine -SH Hydrogen bonding/disulphide bridging. 
Histidine -Imidazole Hydrogen bonding/electrostatic 
Lysine -NH3
+
 Electrostatic 
Arginine -NH3
+
 Electrostatic 
Aspartic acid -COO
-
 Electrostatic 
Glutamic acid -COO
-
 electrostatic 
 
Mechanism of Enzyme Catalysis 
Many different mechanisms by which enzymes bring about catalysis are 
known.  Two such mechanisms are:  
1. General acid-general base mechanism 
2. Nucleophilic mechanism 
 
17 
 
 
General Acid-General Base mechanism. 
A general acid or base is a compound that is weakly ionizable.  At 
physiological pH, the protonated imidazole group of histidine acts as a general acid 
while the free imidazole acts as a general base. 
The role of the imidazole groups is exemplified in the active site of 
Ribonuclease (RNAse A) 
4
.  This enzyme is a pancreatic enzyme found in 
ruminants and is responsible for the breakdown of excess RNA produced in the 
stomach by bacteria and other microorganisms. 
The hydrolytic mechanism of RNAse A outlined in Figure 2 is a two-step 
process that involves the obligatory formation of a cyclic 2’, 3’-phosphoribose 
nucleotide intermediate.  In the first stage of the mechanism, His 119 protonates 
the phosphodiester, and in a concerted manner, His 12 acts as a general base by 
abstracting a proton from the ribose-3’-hydroxyl group forming a nucleophile.  
This nucleophile attacks the phosphate group forming the cyclic intermediate and 
breaking the RNA chain.  The cyclic intermediate is broken down in the second 
step by a reversal of the first step with water replacing the leaving group.  The 
histidines are reverted to their original states. 
18 
 
 
Figure 2.  Role of Imidazole in the active site of RNAseA
4
 
Nucleophilic Mechanism. 
In this mechanism, the attack of a nucleophilic group on the substrate results 
in an enzyme-substrate intermediate that is more labile compared to the original 
substrate. 
Trypsin, chymotrypsin, and thrombin are serine protease enzymes that use 
this mechanism.  Another good example is the salicylic acid binding protein 2 
(SABP2)
5
 that is responsible for the hydrolysis of methyl salicylate to salicylic acid 
during the defense mechanism against pathogens in the tobacco plant.  In the above 
19 
 
enzymes, a catalytic triad is observed.  This triad is made up of the –COO- group of 
aspartic acid, the imidazole group of histidine, and the –OH group of serine. 
The hydrolysis of a peptide bond by chymotrypsin is initiated by a 
nucleophilic attack by the alkoxide nucleophile of the Ser 195 residue.  This 
nucleophile is formed by hydrogen transfer from the –OH group to the imidazole 
group.  This transfer is stabilized by the –COO- group (Figure 3).  The alkoxide 
attack results in the release of the amino terminal of the protein and the formation 
of an acylated enzyme.  The acylated enzyme is then subsequently broken down by 
a reversal of the reaction pathway with water acting as a nucleophile (Figure 3). 
 
Figure 3.  Nucleophilic catalysis in active site of chymotrypsin
4
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Previously Studied Models 
We have shown so far that at the physiological pH of the body, some groups 
have very high catalytic activities and that these groups act as either general acids, 
bases, or nucleophiles.  Many early scientists have explored the properties of these 
catalytic groups to study and shed more light on their mechanism of action. 
As early as the 1950s, L. J Edwards studied in great details the hydrolysis of 
aspirin.  In the last decade, his work has been adapted into a laboratory exercise for 
undergraduate students
6
.  In his work, Edwards showed that the mechanism of 
hydrolysis of aspirin is pH dependent.  The mechanism changes from specific acid 
to general base nucleophilic assisted to specific base as the pH was increased.  The 
general base nucleophilic assisted mechanism occurred between pH of 4.5 and 8.5; 
within this range the carboxylic acid group exists in the deprotonated form as 
carboxylate.  
The kinetics of aspirin hydrolysis was monitored using a UV 
spectrophotometer by measuring the absorbance of the product formed at 298 nm; 
the isosbestic point of the salicylic acid-salicylate ion pair.
6
  The observed rate was 
consistent with general base nucleophilic assisted mechanism.  This mechanism 
involved the carboxylate ion deprotonating a water molecule, forming a strong 
nucleophile that attacks the ester, bringing about its own hydrolysis (Figure 4).  
21 
 
 
Figure 4.  General base nucleophilic assisted hydrolysis of aspirin
6
 
In 1968, Fresht and Kirby studied the intramolecular hydrolysis of the nitro- 
derivatives of aspirin
7, 8
.  Unlike the case of aspirin, they observed that the rate of 
hydrolysis is independent of pH between 4 and 8.  In contrast to the mechanism 
proposed earlier by Edwards (Figure 4), a mechanism involving a direct 
nucleophilic attack by the carboxylate group on the ester function resulting into an 
intermediate anhydride was proposed (Figure 5).  The anhydride is subsequently 
broken down in a rate determining step by general base mechanism involving an 
alkoxide ion.  It was observed also that the overall reaction rate was 50 times faster 
compared to hydrolysis of aspirin
7
.  This rate enhancement was attributed to the 
increased stability of the phenoxide intermediate, which makes a good leaving 
group.   
22 
 
 
Figure 5.  Nucleophilic hydrolysis of 3, 5- dinitroaspirin
7
 
In 1983, Katherine and Kirby studied the hydrolysis of bis-2-carboxyphenyl 
phosphate
9
.  Results showed that the hydrolysis was fastest around pH 4.5.  At this 
pH, the molecule exists in the dianion form.  A mechanism involving an initial 
nucleophilic attack by the carboxylate group to form a cyclic phosphate ester was 
proposed.  This nucleophilic attack was followed by a rather inefficient general 
acid attack by the –COOH group (Figure 6). 
23 
 
 
 
Figure 6.  Hydrolysis of bis-2-carboxyphenyl phosphate
9
 
We have so far looked at some model compounds bearing –COOH groups. 
Extensive investigation of imidazole catalysis dates back to 1973.  Gary A. Rogers 
and Thomas C. Bruice inspired by the participation of an imidazolyl group in the 
catalytic action of serine esterases, synthesized and studied model compounds to 
investigate the influence of electronic and steric factors on the intramolecular 
imidazole catalysis
10
.  Based on their findings, they concluded that three modes of 
intramolecular imidazole catalysis of ester hydrolysis can take place: (1) general 
acid assisted water attack, (2) general base assisted water attack, and (3) O       N 
acetyl transfer to imidazole anion followed by subsequent hydrolysis. 
24 
 
Recently, Elisa S. Orth et al. have shown that two imidazole group can assist 
in the hydrolysis of phosphodiesters.  They found that Bis(2-(1-methyl-1H-
imidazolyl)phenyl) phosphate (BMIPP) auto catalyzes its own hydrolysis
1
.   Based 
on both hydrolysis experiments and computational evidence, they proposed a 
concerted intramolecular nucleophilic catalysis and intramolecular general acid 
catalysis (path B).  Their conclusion was based on the detection of the short-lived 
intermediate INT (Scheme 1) 
 
Scheme 1.  Mechanism for the rapid hydrolysis of BMIPP
1
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Research Prospective 
Our initial research plan was to synthesize and study two model enzyme 
systems.  Enzyme model compounds in model system 1can recognize the substrate 
through π – π stacking.  This model system involves either two carboxylic groups 
or two imidazole rings anchored on an anthracene ring as a spacer (Scheme 2).  
The substrate for this model would be a 9 – anthylphosphate (4).  The two 
anthracene rings, of both the catalyst and the substrate, would recognize each other 
in a highly ordered manner by π – π interactions; such recognition allows both the 
catalytic groups and the phosphate ester of the substrate to be brought into close 
proximity, thus resulting in hydrolysis of the phosphate ester by general acid – 
base mechanism.  Model system 2 involves attaching both the phosphate ester 
(substrate) and the catalytic groups (either carboxylic groups or imidazole rings) to 
the same anthracene spacer (Scheme 2). 
Our synthetic approach for 9 – anthylphosphate was modified after facing 
synthetic problems.  Maintaining the same initial idea of involving anthracene, we 
decided to use dimethoxyl-9-anthylphosphate substrate (5).    
In related work, we later explored the synthesis of yet a third model system 
(model system 3), in which both the catalytic imidazole rings (or the carboxyl 
groups) and the phosphate ester substrate are attached to a benzene ring (Scheme 
2). 
26 
 
Model system1 
 
Substrates (4 and 5) for model compounds 1 through 3. 
Model system 2 
 
IM- Imidazole 
Model 3 
Scheme 2.  Target enzyme model compounds planned for this research 
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CHAPTER 2 
EXPERIMENTAL 
General Method 
All commercial reagents were purchased and used without further 
purification except where otherwise stated.  Organic solvents were distilled prior to 
use, over proper drying agents. 
Proton (
1
H) and carbon-13 (
13
C) (decoupled) NMR spectra were recorded on 
JEOL- NMR Eclipse spectrophotometer operating at 400MHz.  The chemical shift 
values are recorded in parts per million (ppm) relative to TMS.  The multiplicity of 
signals is recorded as such; singlet (s), doublet (d), triplet (t) and multiplet (m). 
Thin layer chromatography (TLC) was carried out using silica gel plates and 
viewed under UV.  Column chromatography separation of compounds was carried 
out using silica gel.  Melting points were obtained using Cambridge Mel-Temp 
instrument and the values are uncorrected. 
Synthesis of 9-Anthranol 
Anthrone (3g, 15.3mmol) was dissolved in freshly prepared 10% NaOH 
(180mL).  The mixture refluxed for 20 mins under nitrogen.  Ice (300g) was added 
to the mixture followed by conc.H2SO4 (15 mL).  Toluene (120mL) was used to 
28 
 
extract the organic compound from the aqueous mixture.  After washing with water 
(200mL), the organic layer was dried over anhydrous Na2SO4.  The organic solvent 
was then evaporated and the resulting solid (1.02g) was dried under vacuum. 
Characterization of the resulting solid by NMR and melting point showed 
unreacted starting material.  No further attempts to synthesize 9 – anthranol were 
made. 
Synthesis of Anthracen-9-yl Hydrogen Phosphate 
Anthrone (2.55mmol) was mixed with 150mg (2.67mmol) of KOH in 25 mL 
of THF.  The mixture was refluxed under nitrogen until all solid dissolved. 
Phosphorus oxychloride (POCl3) (5.35mmol) was dissolved in ice-cold THF 
(10 mL).  The anthrone/KOH solution was then added drop wise to the POCl3 
solution and left to react for 2 hours.  Water (0.5mL) was then added to the mixture 
and stirred overnight. 
Tetrahydrofuran, THF, was removed under reduced pressure.  A mixture of 
methanol (5mL) and water (3mL) was added to the resulting solid and left standing 
overnight.  The resulting solid (0.53g) was then filtered out and dried under 
vacuum. Characterization of this solid by melting point and then NMR was 
consistent with the structure of anthrone. 
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Synthesis of Anthraquinone-1,8-dicarboxylic Acid 
1,8 –Dichloroanthraquinone (20g, 72.4 mmol) and cuprous cyanide (20g, 
216 mmol) were stirred overnight under reflux in N,N-dimethylacetamide(150mL) 
under dry nitrogen gas.  The hot solution was poured into a beaker containing 1L 
of water with stirring.  The copper (I) complex precipitate was filtered and digested 
in 150mL of hot 3N HNO3 to afford the 1,8 – anthraquinonedinitrile. 
The crude dinitrile was hydrolyzed in 80% H2SO4 acid at 170
o
C for 4 hours. 
The hot solution was slowly poured into ice and the precipitate was filtered, 
washed with water, and redissolved in 10% NaOH.  The resulting slurry was then 
filtered.  The filtrate was acidified with 6M HCl to yield crude product.  The 
product was recrystallized from water to yield fine-brown crystals (16 g, 77%, m.p. 
297
o
C-300
o
C, lit 305
o
-311
o
). 
Synthesis of Anthracene-1,8-dicarboxylic Acid (2) 
Anthraquinone -1,8-dicarboxylic acid (7.5 g, 25.33mmol) was stirred with 
Zn dust and copper (II) sulfate at reflux in 300 mL aqueous ammonia solution 
(20%) overnight.  The hot amber solution was filtered, cooled, and acidified with 
conc. HCl.  Crude product was recrystallized from aqueous dioxane to yield 
anthracene-1,8-dicarboxylic acid (4 g, 75%, m.p. 297
0
C-300
0
C (decomposed)). 
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Synthesis of 9-Hydroxylanthracene-1,8-dicarboxylic Acid 
Anthraquinone-1, 8-dicarboxylic acid (1 g, 3.62 mmol) was suspended in 
glacial acetic acid and freshly prepared solution of SnCl2 and 37% HCl was added. 
The mixture was then stirred overnight at room temperature.  The mixture was 
subsequently poured into 100 mL of water and stirred for 1 hour.  The solution was 
extracted with methylene chloride (2×100 ml) and the organic layer was dried over 
anhydrous sodium sulfate and evaporated on the rotavap to yield 0.8 g of product.  
The NMR spectrum of the material was consistent with starting material. 
Synthesis of 1,8-Dimethoxylanthracenedione 
Dihydroanthraquinone (4 g, 16.65 mmol) and K2CO3 (5 g, 33.3 mmol) was 
dissolved in 100 mL of acetone and Me2SO4 (3.5 mL, 33.3 mmol) was added and 
stirred for 30 min at room temperature.  The mixture was then refluxed for 20 
hours.  The solution was filtered and evaporated and the resulting solid was 
washed with excess water.  The product was purified by column chromatography 
with methylene chloride as the mobile phase giving a yield of 3.71 g (83.07%), 
(m.p. 210-215
0
C) 
Synthesis of 1,8-Dimethoxyl-9-hydroxyanthracene (5) 
1, 8-Dimethoxyanthracenedione (0.5 g, 1.87mmol) was suspended in glacial 
acetic acid (50 mL).  A solution of SnCl2 (4 g, 15.6 mmol) in HCl (15 mL) was 
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added in one portion and the suspension was stirred for 30 mins at room 
temperature.  The mixture was poured into water (500 mL) and stirred for 
additional 10 mins. The organic portion was then extracted with methylene 
chloride, and the extract was washed with water (3×100 mL), saturated NaHCO3 
(2×100 mL), and rinsed with water (100 mL).  The methylene chloride solution 
was dried with sodium sulfate and purified by column chromatography to provide 
0.1 g (20%) of product.  
Synthesis of 2,2'-Anthracene-1,8-diylbis(1H-imidazole) (1) 
1,8- Dimethoxylcarbonylanthracene (514.2 mg, 17.47 mmol) was added to 
1.5mL of freshly distilled ethylenediamine.  The reaction mixture was then 
refluxed under nitrogen atmosphere for 8 hours.  Excess ethylenediamine was 
distilled under reduced pressure leaving a brownish solid.  Several attempts were 
made to characterize this product by NMR but all were unsuccessful as it was not 
soluble in any of the common NMR solvents.  The product was also insoluble in 
hot phenyl ether and toluene and hence could not be used in subsequent oxidation 
steps.  
Synthesis of 2-(2’- Hydroxyphenyl)imidazole 
Wintergreen oil (4.23 mL, 33 mmol) was dissolved in 3 molar excess of 
ethylenediamine and the mixture was refluxed overnight under a stream of dry 
32 
 
nitrogen gas.  The unreacted ethylenediamine was distilled under reduced pressure 
and the resulting solid was washed with methylene chloride to remove trace 
amounts of wintergreen oil and ethylenediamine.  The remaining solid was then 
recrystallized from 95% ethanol to obtain pale yellow crystals of 2-(2’-
hydroxylphenyl) -1H-imidazoline. (3.63 g, 67.2%, m.p. 190
o
 – 195o) 
The imidazoline (1.8 g, 11 mmol) was suspended in 12mL of phenylether 
and heated until it dissolved.  Palladium supported on carbon (Pd/C) (153.6 mg) 
was added to the mixture while stirring and the mixture was refluxed for 5 hours.  
The Pd/C catalyst was filtered and filtrate was loaded on a silica gel column and 
eluted with benzene.  The solid obtained was recrystallized from water.  (900 mg, 
50.64%, m.p. 131
o
 – 133o, lit 133o – 134o) 10. 
Synthesis of 2-Hydroxyisopthalic acid 
Potassium hydroxide (120 g, 2.35 mol) was dissolved in 50 mL of water.   
After the mixture cooled to room temperature, 3-methylsalicylic acid (20.00 g, 
131.46 mmol) was added, and the slurry was stirred gently until all the acid 
dissolved.  Lead dioxide (120.00 g, 501.67 mmol) was then stirred and the mixture 
was heated until the temperature reached 250
o
C.  The mixture was kept at this 
temperature for 15 minutes then cooled to room temperature.  Water (250 mL) was 
added to the mixture with stirring.  The cold suspension was then filtered and the 
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solid was washed with 100 mL of water.  The filtrate and washing were combined 
and the mixture was partially acidified using HCl (35%, 80 mL).  Sodium sulfide 
was added to the mixture to precipitate any excess lead as PbS.  The suspension 
was brought to gentle boiling and then allowed to cool to coagulate the lead 
sulfide, which was then filtered.  The filtrate was cooled down to 10
o
C and 
acidified with conc. HCl (90 mL) to precipitate the diacid.  The diacid was filtered 
out and recrystallized from water. (9.84 g, 47.33%, m.p. 238
o
 – 240o) 
Synthesis of Dimethyl-3-carboxysalicylate 
2-Hydroxylisopthalic acid (5 g, 27.4 mmol) was dissolved in freshly distilled 
methanol (75 mL) and 10 drops of concentrated sulfuric acid was added to the 
mixture.  The mixture was then refluxed for 6 hours.  Excess methanol was 
removed on the rotavap.  The obtained solid was suspended in 5% NaHCO3 
solution (150 mL) and extracted with methylene chloride.  The methylene chloride 
layer was dried over anhydrous sodium sulfate and evaporated to give the diester. 
Recrystallization from ethylacetate – hexane mixtue provided fine white crystals of 
the diester. (2.45 g, 57.63%, m.p.65
o
 – 68o) 
The NaHCO3 washing was acidified with HCl and the obtained solid was 
filtered.  The solid was dissolved in methylene chloride and chromatographed on a 
silica gel column eluted with methylene chloride.  The isolated mono-ester (2-
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hydroxy-3-(methoxycarbonyl)benzoic acid) was recrystallized from a mixture of 
acetone-petroleum ether.  (1.3 g, 40 %,m.p. 130
o
 – 132o) 
Synthesis of 2,6-Di(1H-imidazol-2-yl)phenol 
Dimethyl-3-carboxysalicylate (500 mg, 2.37 mmol) was refluxed in 2 mL of 
ethylenediamine overnight under nitrogen.  Excess ethylenediamine was distilled 
under vacuum.  The residue was suspended in 12 mL of phenylether and 150 mg of 
Pd/C was added and the mixture was refluxed for 7 hrs.  The charcoal was filtered 
and the product eluted from a silica gel column using a CH2Cl2/methanol mixture.  
(90 mg, 16.78%, m.p.195
o
C – 200oC, 1HNMR (400MHz, CD3OD) δ 6.9 (1H, t), δ 
7.2 (4H, s), δ 7.9 (2H, d) 13CNMR (100MHz, CD3OD) δ 116, 122, 126, 146, 154) 
Synthesis of 2-Hydroxy-3-(1H-imidazol-2-yl)benzoic acid 
2-Hydroxy-3-(methoxycarbonyl)benzoic acid (300 mg, 1.53 mmol) was 
dissolved in 2mL of ethylenediamine and refluxed overnight under nitrogen. 
Excess ethylenediamine was distilled under reduced pressure.  Traces of 
ethylenediamine were removed using a vacuum pump.  The product obtained was 
then suspended in 4mL of phenylether and 300 mg of Pd/C added to the mixture.  
The mixture was then refluxed overnight and monitored by TLC.  The product was 
purified by silica gel column eluted with CH2Cl2/methanol mixture to give 30 mg 
of product. (
1
HNMR (400 MHz, CDCl3, ppm) δ 6.83(1H, t), δ 7.04 (1H, d), δ 7.10 
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(2H, s), δ 7.22(t),δ 7.55 (1H, d) 13CNMR (100MHz, CDCl3, ppm) δ 113.50, 117.50, 
118.50, 124.0, 130.50, 146.50, 157.00) 
Synthesis of Methyl 2-({hydroxy[2-(1H-imidazol-2-
yl)phenoxy]phosphoryl}oxy)benzoate  
Potassium salicylate (300 mg, 1.856 mmol) was dissolved in dry THF (15 
mL) and PCl5 (386 mg, 1.856 mmol) was added to the reaction mixture.  The 
mixture stirred for 120 minutes under nitrogen. 2-(2’- Hydroxyphenyl)imidazole10 
(300 mg, 1.856 mmol) was then added and the mixture was stirred for 120 more 
minutes.Water (0.5 mL) was added to the mixture and THF was evaporated in the 
hood.  Saturated NaHCO3 (1 mL) was added followed by methanol (5 mL) and the 
precipitate obtained was collected by filtration. 
 The above procedure was repeated in pyridine as solvent instead of THF.  
The product was obtained as a sodium salt.  (
1
HNMR (400MHz, DMSO, ppm) 
δ3.70 (3H, s), δ 6.9(1H, t),δ 6.9(1H, d), δ 7.05(1H, t), δ 7.20(2H, s), δ 7.40 (1H, t), 
δ 7.55 (2H), δ 7.85(1H, d)) 
Synthesis of N-(2-aminoethyl)-3-{2-[(2-aminoethyl)amino]-2-oxoethyl}-
2-hydroxybenzamide 
Dimethyl-3-carboxysalicylate (1.5 g, 7.19 mmol) was dissolved in 
acetonitrile (15 mL).  Ethylenediamine (1.0 mL) was added and the mixture was 
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refluxed until product precipitated out completely.  The product was filtered and 
dried in vacuo.  (m.p. 180
o
 – 183o), ( 1HNMR (400 MHz, CD3OD) δ8.0 (2H, d), δ 
6.50 (1H, t), δ5.0 (4H, s), δ 3.6 (4H, t), δ 3.00 (4H, t), 13CNMR (100MHz, CD3OD) 
δ 170.0, 134.0, 120.0, 112.0, 40.0, 38.0) 
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CHAPTER 3 
RESULTS AND DISCUSSION 
Synthesis of Compounds in Model System 3 
Synthesis of 2,6-Di(1H-imidazol-2-yl)phenol(17) 
2,6-Di(1H-imidazol-2-yl)phenol was obtained as pale yellow solid from the 
synthetic pathway proposed in Scheme 4.  The initial step involved the synthesis of 
dimethyl-3-carboxysalicylate (16) from 3- methylsalicylic acid (13) shown in 
Scheme 3.  The scheme involves the oxidation of the methyl group of (13) using 
PbO2 under high temperature followed by the esterification of the resulting diacid 
(14) yielding the diester (16) as the major product and the monoester (15) as a 
minor product
11
. (Scheme 3) 
 
Scheme 3.  Synthesis of the esters 15 & 16 
The next step in the synthesis involves a reaction between the diester (16) 
and ethylenediamine to yield an imidazoline that is subsequently oxidized in the 
presence of Pd/C
10
 at very high temperatures to the imidazole (17). (Scheme 4) 
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Scheme 4.  Synthesis of 2,6-di(1H-imidazol-2-yl)phenol(17) 
2,6-Di(1H-imidazol-2-yl)phenol (17) was purified by column 
chromatography using 5% methanol / CH2Cl2mixture.  The yield was very low 
(~16%).  The structure of the compound was confirmed using NMR.  The proton 
NMR showed three peaks; a doublet and triplet at δ7.9 and δ6.9 ppm respectively 
corresponding to aromatic protons of the benzene ring and a singlet at δ 7.2 ppm 
corresponding to the imidazole proton.  To further correlate the proton NMR to 
structure, the integration of the individual peaks was calculated.  The singlet 
corresponding to the imidazole showed 4 times the value for the triplet that 
corresponds to a single proton on the benzene ring.  The doublet was twice as 
intense as the triplet corresponding to the other two protons on the ring that are 
equivalent.  The 
13
C NMR showed 6 peaks in the aromatic region (δ110-160 ppm) 
that corresponded to 5 pairs of equivalent carbons (2 pairs have same chemical 
shift) and 2 unequivalent carbons thus further confirming the structure. 
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Even though the NMR techniques confirmed the structure of 17, the overall 
synthetic pathway is inefficient due to the resulting low yield.  The low yield is 
thought to come about as a combined effect of insolubility and catalyst poisoning. 
During the reaction after the ethylenediamine has been distilled, the resulting 
product was observed to be thick brownish viscous oil that was insoluble in both 
cold and hot phenyl ether.  When the Pd/C was added to the solution, it was 
observed to stick to the oil and settle at the bottom of the reaction flask rendering it 
inactive.  Other dehydrogenation procedures found in literature
12
 were attempted, 
but all failed due to similar solubility issues.  
An alternative synthetic pathway was adopted via the formation of the 
diamide. (Scheme 5) 
 
Scheme 5.  Alternative proposed pathway for synthesis of 17 
In this pathway, the synthesis of compound 17 from the diamide was attempted in 
different solvents.  The diamide (18) was insoluble in all attempted solvents except 
40 
 
DMSO
13
.  The initial reaction is a dehydration reaction that should result in ring 
formation giving the imidazoline product.  The following oxidation step of 
imidazoline to imidazole resulted in total decomposition to intractable product. 
Synthesis of 2-Hydroxy-3-(1H-imidazol-2-yl)benzoic Acid(19) 
2-Hydroxy-3-(methoxycarbonyl)benzoic acid (15) was isolated as a side 
product.  Based on knowledge of the catalytic importance of both the –COOH 
group and the imidazole group, 2-hydroxy-3-(1H-imidazol-2-yl)benzoic acid 
would be a very interesting compound to study.  It was also thought it would pose 
less solubility issues compared to previous models.  A synthetic scheme (Scheme 
6) was used based on literature procedures and methods already discussed earlier.  
 
Scheme 6.  Scheme for the synthesis of 2-hydroxy-3-(1H-imidazol-2-yl)benzoic 
acid (19) 
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The imidazole was eluted from a silica gel column using methanol/CH2Cl2 
solvent system.  Proton NMR showed the imidazole peak as a singlet at δ7.1ppm 
and two doublets and a triplet at δ7.55, δ7.05, and δ6.85 ppm respectively.  A 
triplet observed at δ7.20 ppm is associated with impurities that could not be 
removed by column chromatography.  A controversy arose from the 
13
C NMR 
where only 7 peaks were observed instead of 9 peaks.  Thus structure could not be 
accurately confirmed by NMR data. 
Interestingly, when the monoester, 2-hydroxy-3-(methoxycarbonyl)benzoic 
acid (15) was allowed to stand in open atmosphere at room temperature, it was 
found to undergo complete auto hydrolysis in 48 hours as confirmed by TLC and 
NMR. 
The auto hydrolysis of 15 is thought to be a nucleophilic general base 
assisted mechanism (Scheme 7).   The initial step of the mechanism is the 
formation of the alkoxide nucleophile, a strong nucleophile.  The alkoxide ion 
formed deprotonates a water molecule to form the OH 
–
 ion, which subsequently 
attacks the ester to form the tetrahedral intermediate.  The intermediate being 
unstable breaks down to the diacid and the methoxide ion. 
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Scheme 7.  Proposed mechanism for hydrolysis of 2-hydroxy-3-
(methoxycarbonyl)benzoic acid (15) 
Synthesis of Methyl 2-({hydroxy[2-(1H-imidazol-2-
yl)phenoxy]phosphoryl}oxy)benzoate (21) 
2-(2’- Hydroxyphenyl)imidazole10 was synthesized (Scheme 8), 
characterized, and used to confirm the structure of the imidazole group of the other 
synthesized compounds.  Based on a similar compound reported in literature
1
, 
attempts were made to synthesize methyl 2-({hydroxy[2-(1H-imidazol-2-
yl)phenoxy]phosphoryl}oxy)benzoate (21) (Scheme 9). 
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2-(2’- Hydroxyphenyl)imidazole was synthesized based on procedure 
outlined by Thomas C. Bruice
10
 (Scheme 8). 
 
Scheme 8.   Scheme for the synthesis of 2 – (2’-hydroxyphenyl)imidazole 
The initial attempt to carry out a reaction between salicylic acid and the imidazole 
was unsuccessful.  The acid functional group of salicylic acid was then protected 
by a methyl ester.  The potassium salt of wintergreen oil was then used and reacted 
with the 2 – (2’-hydroxyphenyl)imidazole to form the compound 21 in very low 
yield (Scheme 9).  Compound 21 was isolated and NMR spectra obtained in 
DMSO were consistent with the assigned structure. 
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Scheme 9.  Synthesis of methyl 2-({hydroxy[2-(1H-imidazol-2-
yl)phenoxy]phosphoryl}oxy)benzoate (21) 
Synthesis of Anthracene – Based Compounds for Model Systems 1 and 2  
(Scheme 2) 
 
Two synthetic routes (Scheme 10) were attempted for the synthesis of 9 – 
anthylphosphate (4).  The first route involved the formation and isolation of the 
alcohol (23)
14
 and the later reaction of compound (23) with POCl3 to form the 
phosphate.  This route was flawed in that the alcohol rapidly oxidizes to the 
anthrone (starting material) under atmospheric conditions hence we were unable to 
isolate the alcohol.  Facing this difficulty, we decided to attempt to synthesize the 
phosphate in situ without isolating the alcohol.  After carrying out the reaction as 
presented in Scheme 10, we were only able to isolate the starting material.  A 
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plausible explanation for this is that the conversion of the alcohol (23) to anthrone 
is faster than the reaction between the alcohol and POCl3.   
 
Scheme 10.  Synthetic scheme used for 9 – anthylphosphate (4) 
In an attempt to circumvent this problem, we modified our substrate from 
compound 4 to compound 5 (Scheme 2).  To synthesize compound 5, we needed to 
synthesize 1, 8 – dimethoxy- 9- hydroxyanthracene15 (26) as an important 
intermediate compound (Scheme 11). 
Despite the similarities of compound 23 (Scheme 10) to compound 26, the 
latter was synthesized successfully.  This was possible because the alcohol 
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function formed was stabilized through intramolecular hydrogen bonds (Figure 7) 
as opposed to compound 23 that had no such stability factor.  Compound 26 was 
isolated in good yield and purified by silica gel column chromatography.   
 
Scheme 11.  Synthetic scheme for model compound 5 
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Figure 7.  Hydrogen bond stabilization of 1, 8 – dimethoxy- 9- hydroxyanthracene 
(26) 
Scheme 10 was adopted to synthesize enzyme models 1 and 2.  These 
compounds are expected to recognize substrates such as compounds 4 and 5 by π – 
π stacking.  Such interaction would bring the catalytic groups in close proximity to 
the phosphate ester leading to catalysis either by general acid – base, nucleophilic, 
or a combination of both. 
 
Scheme 12.  Scheme for synthesis of 2,2'-anthracene-1,8-diylbis-1H-imidazole (1) 
Anthracene-1, 8-dicarboxylic acid, compound 2 was synthesized according 
to literature
16
.  It was isolated in good yield and its data consistent with literature.  
Synthesis of compound 1 from compound 2 as shown in Scheme 12 is presumably 
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involving an imidazoline intermediate through reaction with ethylenediamine.  The 
reaction gave a product that we were unable to adequately characterize and confirm 
it as the imidazoline intermediate due to solubility problems.  The synthesis was 
however continued based on the assumption that the product was the imidazoline.  
Oxidation over Pd/C gave a product that was insoluble in all common solvent, and 
was not pursued any further. 
Conclusion 
2,6-Di(1H-imidazol-2-yl)phenol has been successfully prepared by a two-
step pathway involving reaction of ethylenediamine and dimethyl-3-
carboxysalicylate followed by dehydrogenation (oxidation) of the imidazoline 
intermediate to the imidazole.  The yield was low, about 16 %.  Other 
dehydrogenation aromatization reactions
12, 17,13
 were attempted to improve the 
yield but were unsuccessful despite their reported successes for similar reactions.  
Another synthetic pathway involving the diamide intermediate was attempted but 
failed due to solubility problems.  Similarly, all attempts to synthesize 2,2’-
anthracene-1,8-diylbis-1H-imidazole were unsuccessful. 
Throughout all attempted synthetic pathways to obtain the imidazole – based 
model compounds, the imidazoline intermediate could not be isolated and 
confirmed.  Syntheses were continued based on the assumption that the 
imidazoline intermediates were formed.   Oxidative aromatization reactions of 
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imidazolines
10, 12, 17
 have been reported in literature.  We believe that in order to 
improve the yield of the desired imidazole products, major improvement in the 
synthesis of the imidazoline intermediates are needed. 
Synthesis of methyl 2-({hydroxy[2-(1H-imidazol-2-
yl)phenoxy]phosphoryl}oxy)benzoate was accomplish although in low yield.  
After initial attempts failed, it was realized that the order of addition of the 
reactants is very important and that converting the phenols to their salts makes 
synthesis easier.  The phenolate salts are more basic and more nucleophilic than 
neutral phenols and thus more reactive with phosphorus pentachloride.  We thus 
recommend the use of the salts of all phenols in the synthesis of methy- 2-
({hydroxy[2-(1H-imidazol-2-yl)phenoxy]phosphoryl}oxy)benzoate. 
The mono ester, 2-hydroxy-3-(methoxycarbonyl)benzoic acid was found to 
undergo auto hydrolysis to produce 2-hydroxylisopthalic acid when exposed to 
open atmosphere.  A nucleophilic, general base assisted mechanism was proposed 
for the hydrolysis process.  Further studies will follow to verify the proposed 
mechanism for this hydrolysis reaction. 
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APPENDICES 
Appendix A 
1
HNMR of 2 – (2’-hydroxyphenyl)imidazole in CDCl3 
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Appendix B 
13
CNMR of 2 – (2’-hydroxyphenyl)imidazole in CDCl3 
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Appendix C 
1
H NMR of 2-hydroxyisophthalic acid (14) in acetone – d6 
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Appendix D 13C NMR of 2 – hydroxyisophthalic acid (14) in acetone - d6 
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Appendix E 
1
H NMR of dimethyl-3-carboxylsalicylate (16) in CDCl3 
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Appendix F 
13
C NMR of dimethyl-3-carboxylsalicylate (16) in CDCl3 
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Appendix G 
1
H NMR of 2,6-di(1H-imidazol-2-yl)phenol (17) in CD3OD 
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Appendix H 
13
C NMR of 2,6-di(1H-imidazol-2-yl)phenol (17) in CD3OD 
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Appendix I 
1
H NMR of 2-hydroxy-3-(1H-imidazol-2-yl)benzoic acid (19) in 
CDCl3 
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Appendix J 
13
C NMR of 2-hydroxy-3-(1H-imidazol-2-yl)benzoic acid (19) in 
CDCl3 
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Appendix K 
1
H NMR of Compound 18 in CD3OD 
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Appendix L 
13
C NMR of Compound 18 in CD3OD 
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Appendix M 
1
H NMR of methyl 2-({hydroxy[2-(1H-imidazol-2-
yl)phenoxy]phosphoryl}oxy)benzoate (21) in DMSO-d3  
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Appendix N 
1
H NMR of 2-(2’-hydroxylphenyl) -1H-imidazoline in D2O 
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Appendix O 
1
H NMR of 1,8-dimethoxylanthracedione (25) in CDCl3 
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Appendix P 
13
C NMR of 1,8-dimethoxylanthracedione (25) in CDCl3 
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Appendix Q 
1
H NMR of 1, 8 – dimethoxy- 9- hydroxyanthracene (26) in CDCl3 
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Appendix R 
1
H NMR of anthraquinone-1,8- dicarboxylic acid (29) in  
acetone-d6 
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Appendix S 
13
C NMR of anthraquinone-1,8- dicarboxylic acid (29) in  
acetone-d6 
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Appendix T 
1
H NMR of product obtained from converting anthrone to 9-anthranol 
(23) in CDCl3 
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Appendix U 
13
C NMR of product obtained from converting anthrone to 9-
anthranol (23) in CDCl3  
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